To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

Clinical trial NCT05017168 · COMPLETED

Trial details

NCT number: NCT05017168
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-10-11
Primary completion: 2021-11-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.